Estimating optimal therapeutic drug levels of anti-tuberculosis medications based on treatment safety and effectiveness.
Gustavo AmorimDavid W HaasMarcelo Cordeiro-SantosAfrânio L KritskiMarina C FigueiredoCody StaatsBrian HacheyMegan TurnerBruno Bezerril AndradeValeria C RollaTimothy R Sterlingnull nullPublished in: medRxiv : the preprint server for health sciences (2024)
Our estimated upper end TDR were higher for INH and lower for RIF compared to currently recommended ranges.